September 7 (SeeNews) - The Bulgarian unit of drug maker Actavis said on Monday its plant in Dupnitsa, in the southwest of the country, passed successfully a review by the American Food and Drug Administration (FDA), allowing it to market its output in the U.S.
about 3 hours agoabout 6 hours agoabout 23 hours agoabout 3 hours agoabout 6 hours agoabout 23 hours agoJun 10, 2026
BucharestJun 30, 2026Marrakech
